Mankind Pharma Ltd Shareholding Pattern

2,581.8
(4.04%)
Feb 3, 2025|03:31:37 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Mankind Pharma Ltd SHAREHOLDING

Dec-2024Dec-2024Sep-2024Jun-2024Mar-2024

Promoter

-

-

-

-

-

Foreign

0%

0%

0%

0%

0%

Indian

72.7%

72.7%

74.86%

74.87%

74.88%

Total Promoter

-

-

-

-

-

Institutions

24.37%

24.39%

22.27%

21.52%

21.01%

Non-Institutions

2.92%

2.89%

2.85%

3.6%

4.1%

Total Non-Promoter

27.29%

27.29%

25.13%

25.12%

25.12%

Custodian

0%

0%

0%

0%

0%

Total

100%

100%

100%

100%

100%

  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 0.00%

Foreign: 0.00%

Indian: 72.70%

Non-Promoter- 24.37%

Institutions: 24.37%

Non-Institutions: 2.92%

Custodian: 0.00%

Mankind Pharma: Related NEWS

Top Stocks for Today - 24th January 2025
24 Jan 2025|07:50 AM

Here are some of the stocks that may see significant price movement today: Indus Towers, Dr Reddy’s Laboratories, Mankind Pharma, etc.

Read More
Mankind Pharma Q3 Profit Falls 16%, Revenue Jumps 24%
23 Jan 2025|11:57 PM

The company reported a good growth in EBITDA of 36.8% to ₹830 crore in the quarter against ₹606.5 crore in Q3 FY24.

Read More
Mankind Pharma Secures ₹5,000 Crore NCDs by Pledging 56.31% Stake in BSV
8 Jan 2025|04:01 PM

The NCDs issued are categorized, rated, secured, redeemable, and transferable, distributed across three series.

Read More
Mankind Pharma, Innovent Join Forces for Cancer Care
26 Dec 2024|12:46 PM

According to the National Cancer Registry Programme, cancer is expected to cause 29.8 million DALYs by 2025, making it a serious health issue in India.

Read More
Mankind Pharma Secures ₹3,000 Crore via QIP for Growth
20 Dec 2024|02:06 PM

The issue price includes a premium of ₹2,519 per share, aggregating a total of ₹2,999.99 crore.

Read More
Mankind Pharma Sees 30% Profit Surge in Q2
6 Nov 2024|10:12 PM

Revenue from operations grew by 13.6% YoY, totaling ₹3,076.5 Crore, up from ₹2,708.1 Crore in Q2 of the previous fiscal.

Read More
Top stocks for today - 6th November 2024
6 Nov 2024|08:08 AM

Here are some of the stocks that may see significant price movement today: Dr Reddy’s, Hindustan Zinc, Titan Company, etc.

Read More
Top stocks for today - 24th October 2024
24 Oct 2024|08:15 AM

Here are some of the stocks that may see significant price movement today: Escorts Kubota, Infosys, Mahindra & Mahindra, etc.

Read More
CCI greenlights Mankind Pharma's Rs 13,630 crore takeover of Bharat Serums
3 Oct 2024|11:02 AM

Mankind announced in July that it would purchase the whole stake in Bharat Serums and Vaccines.

Read More
Top 10 stocks for today – 3rd October 2024
3 Oct 2024|09:07 AM

Here are some of the stocks that may see significant price movement today: Suzlon Energy, Aurobindo Pharma, Coal India, etc.

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.